Market Place
Sourcing Support
Locus Biosciences Announces Positive Phase 2 Results In The Lancet
12 Aug 2024 //
GLOBENEWSWIRE
Locus Biosciences Announces $23.9 Million in Funding from BARDA
23 Jan 2024 //
GLOBENEWSWIRE
Locus Announces First Patient Treated in the ELIMINATE Ph2/3 Trial of LBP-EC01
13 Sep 2022 //
GLOBENEWSWIRE
Locus closes $35M financing, zeros in on antibiotic resistance
19 May 2022 //
FIERCEBIOTECH
Locus Biosciences Announces $35 Million Financing
18 May 2022 //
GLOBENEWSWIRE
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
19 Oct 2021 //
GLOBENEWSWIRE
Locus completes first-of-its-kind controlled clinical trial for CRISPR
24 Feb 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.